Name: Return on Equity (ROE)

Definition: ROE shows how much profit the company earns for its shareholders based on their invested equity. It’s one of the most watched profitability ratios. A consistently high ROE signals strong management and efficient use of shareholder capital. But artificially high ROE may sometimes be boosted by excessive debt.

Interpretation:
• In '2021', RVTY's return on equity was 13.2%, measuring profitability for shareholders. Industry average for Biotechnology: Laboratory Analytical Instruments in '2021' stood at 18.0%.
• In '2022', RVTY's return on equity was 7.8%, measuring profitability for shareholders. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Laboratory Analytical Instruments in '2022' stood at 27.9%. Industry average increased by 9.9% compared to previous year.
• In '2023', RVTY's return on equity was 9.1%, measuring profitability for shareholders. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Laboratory Analytical Instruments in '2023' stood at -10.8%. Industry average declined by 38.7% from previous year.
• In '2024', RVTY's return on equity was 3.5%, measuring profitability for shareholders. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Laboratory Analytical Instruments in '2024' stood at -35.6%. Industry average declined by 24.9% from previous year.
Overall, RVTY's return on equity has been volatile but showed a downward trend over the past 4 years.

Formula: ROE = Net Income / Shareholders' Equity

Good Range: 10%-20% desirable for many industries.